Fannie Mae, Freddie Mac shares tumble after conservatorship comments
Russell Joyce, a director at Celsius Holdings , Inc. (NASDAQ:CELH), recently sold 4,000 shares of the company’s common stock. The shares were sold at an average price of $28.47, resulting in a total transaction value of approximately $113,880. The transaction comes as Celsius, currently valued at $6.2 billion, has shown strong momentum with an 8% gain over the past week, despite trading at a relatively high P/E ratio of 58x. This sale was conducted on March 11, 2025, and was part of a move to satisfy tax withholding obligations upon the vesting of restricted stock units. Following this transaction, Joyce holds 19,106 shares in the company. According to InvestingPro analysis, Celsius maintains strong financial health with a current ratio of 3.6x and holds more cash than debt on its balance sheet. The company’s comprehensive financial analysis, including 18 additional ProTips and detailed valuation metrics, is available in the Pro Research Report.
In other recent news, Celsius Holdings announced its anticipated acquisition of Alani Nutrition LLC, with the deal expected to close in April 2025. This follows the expiration of the Hart-Scott-Rodino Antitrust Improvements Act waiting period, a necessary step for the transaction. The acquisition involves Celsius purchasing all issued and outstanding membership interests in Alani Nu, subject to standard closing conditions. In a separate development, Celsius Holdings appointed Eric Hanson as its new President and Chief Operating Officer, effective March 24, 2025. Hanson brings extensive experience from his previous role at PepsiCo (NASDAQ:PEP), where he managed a portfolio generating over $3 billion in annual revenue.
Analyst firms have responded positively to these developments. Needham analysts raised the stock target for Celsius Holdings to $40, maintaining a Buy rating, citing the Alani Nu acquisition as a positive move for financial performance. Jefferies also increased its price target to $40, with optimism stemming from Celsius’s stronger-than-expected fourth-quarter performance and the acquisition’s potential to boost sales and EBITDA. Both firms highlight the accretive nature of the Alani Nu deal and its expected contribution to Celsius’s market expansion. These developments come as Celsius continues to focus on growth opportunities within the functional beverage sector.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.